Gene · 970
NIH grants2,135
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 2,135
Download this page as JSON| Grant | Title | CD70 papers | Newest fiscal year |
|---|---|---|---|
| R24GM137782 | National Glycoscience Resource- CCRC Service and Training - NGlycoR@CCRC | 1 | 2025 |
| R35CA196620 | Molecular mechanisms of antibody-mediated immunotherapies | 1 | 2025 |
| R35CA197745 | Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level | 1 | 2025 |
| R35CA241894 | Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies. | 1 | 2025 |
| R35GM118119 | Assembly and function of cytoskeletal systems in eukaryotic and prokaryoticcells | 1 | 2025 |
| R35GM119770 | Multi-cellular and multi-scale systems modeling to understand the dynamics of the human immune system in interdisciplinary applications | 1 | 2025 |
| R35GM122451 | Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution | 1 | 2025 |
| R35GM128938 | Studying the function of human genetic variation in the light of 3D genome organization | 1 | 2025 |
| R35GM133552 | Coordination of chaperone interactions that dictate protein folding and trafficking | 1 | 2025 |
| R35GM134864 | Nanoscale programing of celluar and physiological phenotypes | 1 | 2025 |
| R35GM145249 | Advancing Proteomics Technologies to Decipher the Ubiquitin-Proteasome System | 1 | 2025 |
| R35HG011922 | Model-based methods for single cell chromatin interactomic data | 1 | 2025 |
| R35HL166565 | Intersection of Obesity and Heart Failure with Preserved Ejection Fraction | 1 | 2025 |
| R35NS111644 | The Role of B cells in the Origin and Progression of Multiple Sclerosis | 1 | 2025 |
| R37AI147868 | The HUSH complex in HIV-1 latency | 1 | 2025 |
| R37CA240822 | Elucidating the Role of Trop2 in Prostate Cancer | 1 | 2025 |
| R37CA248478 | Proteomic determinants of response to checkpoint blockade in malignant pleural mesothelioma | 1 | 2025 |
| R37CA258829 | Mechanisms of liver metastasis and associated resistance to immunotherapy | 1 | 2025 |
| R37CA259177 | Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene. | 1 | 2025 |
| R37CA269499 | Immunometabolic pathways enabled by PARP inhibition in breast cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/grants?page=14